{"id":"W3130048594","doi":"10.1158/1538-7445.sabcs20-pd1-05","title":"Abstract PD1-05: Latest findings from the breast cancer cohort in SUMMIT - a phase 2 ‘basket’ trial of neratinib + trastuzumab + fulvestrant for <i>HER2</i>-mutant, hormone receptor-positive, metastatic breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Neratinib; Medicine; Fulvestrant; Trastuzumab; Internal medicine; Metastatic breast cancer; Oncology; Breast cancer; Population; Cancer; Estrogen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001474361,0.0005786839,0.001361304,0.0002554652,0.0003544316,0.0001244556,0.0005444265,0.0002170812,0.003416905],"category_scores_gemma":[0.0002092882,0.00044796,0.0003552223,0.001636516,0.0008028166,0.000407717,0.0001263149,0.001414775,0.0000112382],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001702981,"about_ca_system_score_gemma":0.004219898,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01999763,"about_ca_topic_score_gemma":0.00867145,"domain_scores_codex":[0.9942459,0.0004049616,0.001157531,0.001216745,0.001586535,0.001388296],"domain_scores_gemma":[0.9954897,0.001512724,0.0003108562,0.0008512366,0.001417836,0.0004176311],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.1766361,0.00298982,0.01986839,0.0005343219,0.002403732,0.0003175645,0.002377762,0.0003698865,0.6967809,0.00008911116,0.009424356,0.08820798],"study_design_scores_gemma":[0.3080786,0.002547741,0.4483207,0.006308093,0.001384615,0.0003005224,0.00516059,0.0005481493,0.2057499,0.0005451615,0.01925851,0.00179737],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9481121,0.01027122,0.00009444539,0.01480212,0.0005866245,0.003934314,0.02206258,0.0000517915,0.00008481486],"genre_scores_gemma":[0.9864882,0.005567966,0.0003659766,0.0004728688,0.001414587,0.004558289,0.00049326,0.0001739506,0.000464877],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4910311,"threshold_uncertainty_score":0.9997972,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06149143344151323,"score_gpt":0.4093802275949686,"score_spread":0.3478887941534553,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}